TuHURA Biosciences
HURA | NASDAQ
$1.33
-$0.06 (-4.32%)
At close: Nov 16, 2026, 4:00 PM ET
$1.37
+$0.04 (+3.01%)
After-hours:
Nov 16, 2026, 7:59 PM ET
-4.32%
(1D)Rating
30.2
+1.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #794/1021 (Top 78%)
Key Statistics
Market Data
Market Cap $84.76M
1D Range
1.27 1.47
52W Range
0.44 3.15
Valuation (TTM)
PE -2.66
PB 4.47
EV/EBITDA -3.30
Valuation (NTM)
Forward PE N/A
Forward PEG 0.28
Price Target $9.00
Cash Flow
FCF Yield -28.1%
SBC Adj. FCF Yield -34.6%
SBC Impact -23.2%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 132.8% |
84.1%
FCF 3Y | 5Y -19.9% |
-10.8%
Returns
ROA -82.6%
ROE -146.8%
ROIC -105.0%
Financial Health
Net Debt
$7.31M
Current Ratio 0.47
Interest Coverage -16.22
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies des...
Sector Healthcare
Industry Biotechnology
Employees 22
IPO Date Feb 22, 2013
Website www.tuhurabio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$9.50
Upside
+614.29%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove HURA